Advertisement

Topics

Mallinckrodt snaps up pediatric jaundice candidate in deal worth potential $425 million

11:51 EDT 4 Aug 2017 | thePharmaLetter

US specialty biopharmaceutical firm Mallinckrodt is to acquire InfaCare Pharmaceutical in a deal that…

Original Article: Mallinckrodt snaps up pediatric jaundice candidate in deal worth potential $425 million

NEXT ARTICLE

More From BioPortfolio on "Mallinckrodt snaps up pediatric jaundice candidate in deal worth potential $425 million"

Quick Search
Advertisement